Literature DB >> 2422647

Human prostate-specific antigen: structural and functional similarity with serine proteases.

K W Watt, P J Lee, T M'Timkulu, W P Chan, R Loor.   

Abstract

The complete amino acid sequence of the prostate-specific antigen (PA) from human seminal plasma has been determined from analyses of the peptides generated by cyanogen bromide, hydroxylamine, endoproteinases Arg-C and Lys-C. The single polypeptide chain of PA contains 240-amino acid residues and has a calculated Mr of 26,496. An N-linked carbohydrate side chain is predicted at asparagine-45, and O-linked carbohydrate side chains are possibly attached to serine-69, threonine-70, and serine-71. The primary structure of PA shows a high degree of sequence homology with other serine proteases of the kallikrein family. The active site residues of histidine, aspartic acid, and serine comprising the charge-relay system of typical serine proteases were found in similar positions in PA (histidine-41, aspartic acid-96, and serine-192). At pH 7.8, PA hydrolyzed insulin A and B chains, recombinant interleukin 2, and--to a lesser extent--gelatin, myoglobin, ovalbumin, and fibrinogen. The cleavage sites of these proteins by PA were chemically analyzed as the alpha-carboxyl side of some hydrophobic residues, tyrosine, leucine, valine, and phenylalanine, and of basic residues histidine, lysine, and arginine. The chymotrypsin-like activity of PA exhibited with the chromogenic substrate N-succinyl-L-alanyl-L-alanyl-L-prolyl-L-phenylalanine p-nitroanilide yielded a specific activity of 9.21 microM per min per mg of PA and Km and kcat values of 15.3 mM and 0.075s-1, respectively. "Trypsin-like" activity of PA was also detected with N alpha-benzoyl-DL-arginine p-nitroanilide and gave a specific activity of 1.98 microM per min per mg of PA. Protease inhibitors such as phenylmethylsulfonyl fluoride, diisopropyl fluorophosphate, L-1-tosylamido-2-phenylethyl chloromethyl ketone, aprotinin, leupeptin, soybean trypsin inhibitor as well as Zn2+ and spermidine were effective inhibitors of PA enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422647      PMCID: PMC323473          DOI: 10.1073/pnas.83.10.3166

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Tertiary structural differences between microbial serine proteases and pancreatic serine enzymes.

Authors:  L T Delbaere; W L Hutcheon; M N James; W E Thiessen
Journal:  Nature       Date:  1975-10-30       Impact factor: 49.962

2.  Cleavage at Asn-Gly bonds with hydroxylamine.

Authors:  P Bornstein; G Balian
Journal:  Methods Enzymol       Date:  1977       Impact factor: 1.600

3.  Crystal structure of bovine trypsinogen at 1-8 A resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin.

Authors:  H Fehlhammer; W Bode; R Huber
Journal:  J Mol Biol       Date:  1977-04-25       Impact factor: 5.469

4.  The crystal and molecular structure of DIP-inhibited bovine trypsin at2.7Angstrom resolution.

Authors:  R M Stroud; L M Kay; R E Dickerson
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1972

5.  Role of a buried acid group in the mechanism of action of chymotrypsin.

Authors:  D M Blow; J J Birktoft; B S Hartley
Journal:  Nature       Date:  1969-01-25       Impact factor: 49.962

6.  The characterization of the alpha-subunits of 7S nerve growth factor.

Authors:  R W Stach; P F Pignatti; M E Baker; E M Shooter
Journal:  J Neurochem       Date:  1980-04       Impact factor: 5.372

7.  The primary structure of porcine glandular kallikreins.

Authors:  H Tschesche; G Mair; G Godec
Journal:  Adv Exp Med Biol       Date:  1979       Impact factor: 2.622

8.  The proteolytic activity of human prostate-specific antigen.

Authors:  Y Ban; M C Wang; K W Watt; R Loor; T M Chu
Journal:  Biochem Biophys Res Commun       Date:  1984-09-17       Impact factor: 3.575

9.  Purification of a human prostate specific antigen.

Authors:  M C Wang; L A Valenzuela; G P Murphy; T M Chu
Journal:  Invest Urol       Date:  1979-09

10.  Postcoital detection of a male-specific semen protein. Application to the investigation of rape.

Authors:  H C Graves; G F Sensabaugh; E T Blake
Journal:  N Engl J Med       Date:  1985-02-07       Impact factor: 91.245

View more
  73 in total

1.  Expression and characterization of trypsinogen produced in the human male genital tract.

Authors:  A Paju; A Bjartell; W M Zhang; S Nordling; A Borgström; J Hansson; U H Stenman
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

2.  Development of a peptide-drug conjugate for prostate cancer therapy.

Authors:  Wanyi Tai; Ravi S Shukla; Bin Qin; Benyi Li; Kun Cheng
Journal:  Mol Pharm       Date:  2011-05-03       Impact factor: 4.939

Review 3.  Morphologic and regulatory aspects of prostatic function.

Authors:  G Aumüller
Journal:  Anat Embryol (Berl)       Date:  1989

4.  Twenty Years of PSA: From Prostate Antigen to Tumor Marker.

Authors:  Gabriela De Angelis; Harry G Rittenhouse; Stephen D Mikolajczyk; L Blair Shamel; Axel Semjonow
Journal:  Rev Urol       Date:  2007

5.  The Drosophila melanogaster seminal fluid protein Acp62F is a protease inhibitor that is toxic upon ectopic expression.

Authors:  Oliver Lung; Uyen Tram; Casey M Finnerty; Marcie A Eipper-Mains; John M Kalb; Mariana F Wolfner
Journal:  Genetics       Date:  2002-01       Impact factor: 4.562

6.  PSA-alpha-2-macroglobulin complex is enzymatically active in the serum of patients with advanced prostate cancer and can degrade circulating peptide hormones.

Authors:  Maya B Kostova; William Nathaniel Brennen; David Lopez; Lizamma Anthony; Hao Wang; Elizabeth Platz; Samuel R Denmeade
Journal:  Prostate       Date:  2018-04-16       Impact factor: 4.104

7.  Equivalent recognition of free and ACT-complexed PSA in a monoclonal-polyclonal sandwich assay is conferred by binding specificity of the monoclonal antibody.

Authors:  Z Zhou; E G Armstrong; A Belenky; J V Freeman; K K Yeung
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

8.  Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brain.

Authors:  Jeremy G Stone; Raj K Rolston; Masumi Ueda; Hyoung-Gon Lee; Sandy L Richardson; Rudy J Castellani; George Perry; Mark A Smith
Journal:  Int J Clin Exp Pathol       Date:  2008-10-20

9.  Recognition of prostate-specific antigenic peptide determinants by human CD4 and CD8 T cells.

Authors:  J M Corman; E E Sercarz; N K Nanda
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

10.  Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen.

Authors:  H Lilja; J Oldbring; G Rannevik; C B Laurell
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.